|
Post by roguesuerte on Mar 28, 2017 20:32:44 GMT -5
What I find most troubling is that even though the re-launch is going badly, to be kind, Mgmt seems have a "this is our plan and we are sticking to it" mentality.They should have bumped up DTC not postponed it another quarter, persued options before announcing r.s. This is not a behemoth of a BP company like SNY, they need to be nimble and roll with the punches instead of getting beat down with their litany of rookie mistakes. I am beyond frustrated with my investment and I am down so big its almost laughable. I cant intervene here and do something to stop this slow motion car crash from playing out but I wonder why the Mann Foundation has not intervened here, or whether they will intervene at some point.
|
|
|
Post by slugworth008 on Mar 28, 2017 20:38:50 GMT -5
What I find most troubling is that even though the re-launch is going badly, to be kind, Mgmt seems have a "this is our plan and we are sticking to it" mentality.They should have bumped up DTC not postponed it another quarter, persued options before announcing r.s. This is not a behemoth of a BP company like SNY, they need to be nimble and roll with the punches instead of getting beat down with their litany of rookie mistakes. I am beyond frustrated with my investment and I am down so big its almost laughable. I cant intervene here and do something to stop this slow motion car crash from playing out but I wonder why the Mann Foundation has not intervened here, or whether they will intervene at some point. DTC should have definitely been bumped up and announced along with the RS - I too wonder why the Mann Foundation hasn't stepped in as well.
|
|
|
Post by promann on Mar 29, 2017 7:13:48 GMT -5
Since nothing has changed from the last cc, I couldn't understand the recent drop from $2.25 to today's drop below $1.70. I did step up and buy more shares this morning only to see it fall even further by the close. I'm still PRAYING for a big announcement with a big cash infusion so we can put in a bottom and slowly climb out of this deep hole. With the numerous local news stations running stories on Afrezza, at some point we have to get some traction. It can't come soon enough. Matt may be a good CFO, but it doesn't look like he is up to the task of CEO. I sure hope he proves me wrong! RS IMO get shorted down to half their value. I think you got a good price. I'd like to hear that Matt has gotten the debt re-done and see scripts gain traction. They can raise money down the line. Anyone going to the shareholder meeting? It's only a month and 1/2 away. I will be there, I couldn't make it last year but I was there the year before and met a lot of nice people. At that time we were all concerned of the stock price in the 3.00 - 4.00 range. incredible. I met Al and toured the plant and was impressed. There were many angry share holders i can only imagine what it will be like this time. Hopefully we get some good script numbers before then and maybe some news to bring up the SP
|
|
|
Post by derek2 on Mar 29, 2017 8:32:26 GMT -5
It occurs to me that we've been thinking about this all wrong. Just like some weeks are short weeks, the last 2 years were short years - Earth years - and so that depressed Rx numbers.
If we use, for example, Neptune years, sales come in not at a measly 12,500 prescriptions per year, but at a hearty 2,062,500 TRx! Now that's what I'm talking about. All this would require is an accounting footnote for the definition of "Year", and pre-book the pro forma number.
|
|
|
Post by Cowgirl on Mar 29, 2017 9:02:24 GMT -5
Rougues...
The Mann Foundation has not intervened because the Mann Foundation owns approximately 40% of Mannkind stock....have you seen the price lately? They have lost almost all their money like us! The Mann Foundation is broke!
|
|
|
Post by lojothehus on Mar 29, 2017 9:06:19 GMT -5
What I find most troubling is that even though the re-launch is going badly, to be kind, Mgmt seems have a "this is our plan and we are sticking to it" mentality.They should have bumped up DTC not postponed it another quarter, persued options before announcing r.s. This is not a behemoth of a BP company like SNY, they need to be nimble and roll with the punches instead of getting beat down with their litany of rookie mistakes. I am beyond frustrated with my investment and I am down so big its almost laughable. I cant intervene here and do something to stop this slow motion car crash from playing out but I wonder why the Mann Foundation has not intervened here, or whether they will intervene at some point. I agree it's time for MNKD to fight back and start doing something more than projecting the future.
|
|
|
Post by tiberious on Mar 29, 2017 9:34:06 GMT -5
Its time for the MANN foundation to publicly back the company until it gets off the ground and scripts rise (like the CIA guy backing Daniel Craig James Bond in Casino Royale after he lost it all). Take BK off the table. So much sand kicked in the face to this company its almost unbelievable... FDA CRL#1, Hamburg, Skrelli, FDA CRL#2, FDA obvious sandbag attempt at the AdComm, restrictive BS Label, Sanofi sandbag job, short manipulation / Hakan, Al's passing, etc, etc.... it has been relentless. SAD for such an effective treatment and novel delivery system. I wonder what Al would do had he been with us to this point.
|
|
|
Post by mnholdem on Mar 29, 2017 10:51:09 GMT -5
It occurs to me that we've been thinking about this all wrong. Just like some weeks are short weeks, the last 2 years were short years - Earth years - and so that depressed Rx numbers. If we use, for example, Neptune years, sales come in not at a measly 12,500 prescriptions per year, but at a hearty 2,062,500 TRx! Now that's what I'm talking about. All this would require is an accounting footnote for the definition of "Year", and pre-book the pro forma number. It's taking every ounce of self-discipline for me not to bring Uranus into this discussion.
|
|
|
Post by alethea on Mar 29, 2017 10:56:45 GMT -5
What I find most troubling is that even though the re-launch is going badly, to be kind, Mgmt seems have a "this is our plan and we are sticking to it" mentality.They should have bumped up DTC not postponed it another quarter, persued options before announcing r.s. This is not a behemoth of a BP company like SNY, they need to be nimble and roll with the punches instead of getting beat down with their litany of rookie mistakes. I am beyond frustrated with my investment and I am down so big its almost laughable. I cant intervene here and do something to stop this slow motion car crash from playing out but I wonder why the Mann Foundation has not intervened here, or whether they will intervene at some point. DTC should have definitely been bumped up and announced along with the RS - I too wonder why the Mann Foundation hasn't stepped in as well. How about because the Mann Foundation has at least a 95% loss like most others and the total value of their 20% ownership of MNKD has dwindled to almost nothing? In other words, their financial resources have been devastated....just like mine.
|
|
|
Post by peppy on Mar 29, 2017 13:38:39 GMT -5
from another thread; " on the electronic board directly in front of me, here comes a thirty second ad for Afrezza," "How Long Do You Wait for Mealtime Insulin to Leave?". It was on a repeating platform of maybe six messages. A nice wink from mischievous angels...
the provider. Context Media Health.
|
|
|
Post by lojothehus on Mar 30, 2017 10:21:03 GMT -5
from another thread; " on the electronic board directly in front of me, here comes a thirty second ad for Afrezza," "How Long Do You Wait for Mealtime Insulin to Leave?". It was on a repeating platform of maybe six messages. A nice wink from mischievous angels... the provider. Context Media Health. Inhaled insulin could be a game changer for diabetes patients
It's a game changer for adults with type 1 and type 2 diabetes. Forget giving yourself a shot or wearing a pump. Now you can inhale insulin. "It's a new design of getting insulin into the system because once you inhale it into your lungs it actually........
fox59.com.
Advertise, Advertise, Advertise, Advertise......and people will buy it!
|
|
|
Post by johntherancher on Mar 30, 2017 11:21:50 GMT -5
It can't hurt anything to breech the question of what is Mannkind worth? It would only take two interested parties to bid and raise the share price. As a corollary, could Mannkind offer to share exclusive rights to some or all of its patents? Maybe reserving US territory?
|
|
|
Post by dreamboatcruise on Mar 30, 2017 13:48:05 GMT -5
It can't hurt anything to breech the question of what is Mannkind worth? It would only take two interested parties to bid and raise the share price. As a corollary, could Mannkind offer to share exclusive rights to some or all of its patents? Maybe reserving US territory? And zero bidders lowers the share price. Yes, companies can license patents with any type of terms they can find a buyer for. I'd assume they have explored and not found anyone wanting to license anything... beyond what we already know about.
|
|
|
Post by hopingandwilling on Mar 30, 2017 13:57:49 GMT -5
What is the next move...just broke below $0.30 pre.RS. Seems there is no floor under the stock! Ouch!Ouch! So much promise..and promises!
|
|
|
Post by sportsrancho on Mar 30, 2017 14:05:16 GMT -5
What is the next move...just broke below $0.30 pre.RS. Seems there is no floor under the stock! Ouch!Ouch! So much promise..and promises! RS get shorted down, if we get to 1.25 / 50% haircut. I'll buy a few more shares:-)
|
|